Last edition
News about Global Pharma
Cognizant and NVIDIA Join Forces to Transform Drug Discovery with Gen AI Technology
The aim is to enhance productivity in the development process and accelerate the pace at which life-saving treatments can reach the market.
Global Pharma | 21/03/2024 | By Abha | 695
Corealis Pharma Lab Facilities to Be Fully Operational by 2024 End
Corealis Pharma Inc. has announced that the expansion project of its state-of-the-art laboratory facilities is completed ahead of schedule
Global Pharma | 21/03/2024 | By Manvi | 742
BerGenBio Begins Phase 2a in First Line NSCLC Patients with STK11m
BerGenBio ASA has initiated Phase 2a portion of the BGBC016 clinical study of its selective AXL inhibitor bemcentinib in combination with standard of care therapy in first-line Non-Small Cell Lung Cancer (NSCLC) patients
Global Pharma | 21/03/2024 | By Manvi | 664
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative
Patients must have been previously treated with CDK 4/6 inhibitors and received at least two prior lines of endocrine therapy in the recurrent or metastatic setting to be eligible for the trial. Puma plans to initiate this trial in the second half of 2024.
Global Pharma | 20/03/2024 | By Manvi | 618
FDA Approves First Gene Therapy for Children with MLD
The U.S. Food and Drug Administration has recently approved Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy
Global Pharma | 20/03/2024 | By Manvi | 477
inHEART Receives FDA Clearance for AI Software Module Enhancing Cardiac Imaging
Previously available to clinicians in the EU, the FDA clearance now enables inHEART to introduce its advanced AI-driven solution to hospitals across the United States.
Global Pharma | 20/03/2024 | By Abha | 487
Everest Medicines' NEFEGAN Receives Approval in Singapore for Treating IgA Nephropathy
Following its successful approval in Macao and mainland China, Singapore becomes the third region in Everest territories to grant New Drug Application (NDA) approval for NEFEGAN®.
Global Pharma | 20/03/2024 | By Abha | 460
AstraZeneca Acquires Fusion Pharmaceuticals to Transform Cancer Treatment
Fusion Pharmaceuticals Inc. has signed a definitive agreement to be acquired by AstraZeneca.
Global Pharma | 20/03/2024 | By Manvi | 808
Panoramic Health and The Kidney and Hypertension Center Join Forces to Elevate Kidney Care in Ohio
Panoramic Health announce its strategic partnership with The Kidney and Hypertension Center (KHC), the largest independent nephrology practice in Cincinnati, Ohio.
Global Pharma | 19/03/2024 | By Manvi | 455
Lunit has secured a supply contract with TeleDiag in France and the Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro; LPCC), providing AI-powered radiology solutions for chest X-ray and breast cancer detection, respectively.
Global Pharma | 19/03/2024 | By Manvi | 204
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy